|Tel||+44 (0)1865 223476|
|Fax||+44 (0)1865 572398|
UK TAVI Trial Manager
I joined SITU as the UK TAVI Trial Manager in August 2016. UK TAVI is an NIHR HTA funded multicentre randomised controlled trial to assess the clinical effectiveness and cost-utility of TAVI, compared with conventional surgical aortic valve replacement (AVR) in patients with severe symptomatic aortic stenosis at intermediate or high operative risk.
Before this I was Assistant Clinical Research Coordinator for Cardiovascular Medicine at the Radcliffe Department of Medicine in the University of Oxford.